Acromegaly: pathogenesis, diagnosis, and management.
Fleseriu M, Langlois F, Lim DST, Varlamov EV, Melmed S.
Lancet Diabetes Endocrinol. 2022 Nov;10(11):804-826. doi: 10.1016/S2213-8587(22)00244-3. Epub 2022 Oct 6.
Growth Hormone Excess: Implications and Management.
Dhaneshwar S, Shandily S, Tiwari V.
Endocr Metab Immune Disord Drug Targets. 2023;23(6):748-763. doi: 10.2174/1871530322666221012155533.
Predicting Subtype of Growth Hormone Pituitary Adenoma based on Magnetic Resonance Imaging Characteristics.
Liu CX, Wang SZ, Heng LJ, Han Y, Ma YH, Yan LF, Yu Y, Wang W, Hu YC, Cui GB.
J Comput Assist Tomogr. 2022 Jan-Feb 01;46(1):124-130. doi: 10.1097/RCT.0000000000001249.
The p300 Inhibitor A-485 Exerts Antitumor Activity in Growth Hormone Pituitary Adenoma.
Ji C, Xu W, Ding H, Chen Z, Shi C, Han J, Yu L, Qiao N, Zhang Y, Cao X, Zhou X, Cheng H, Feng H, Luo C, Li Z, Zhou B, Ye Z, Zhao Y.
J Clin Endocrinol Metab. 2022 May 17;107(6):e2291-e2300. doi: 10.1210/clinem/dgac128.
Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma.
Tucker DW, Pangal DJ, Du R, Gogia AS, Tafreshi A, Ruzevick J, Hurth KT, Triche T Jr, Micko A, Carpten JD, Shiroishi MS, Carmichael JD, Rhie SK, Zada G.
PLoS One. 2023 Apr 27;18(4):e0284949. doi: 10.1371/journal.pone.0284949. eCollection 2023.
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors.
Bianchi A, Chiloiro S, Giampietro A, Gaudino S, Calandrelli R, Mazzarella C, Caldarella C, Rigante M, Gessi M, Lauretti L, De Marinis L, Olivi A, Pontecorvi A, Doglietto F.
Front Endocrinol (Lausanne). 2023 May 3;14:1123267. doi: 10.3389/fendo.2023.1123267. eCollection 2023.
Plurihormonal pituitary adenoma with concomitant adrenocorticotropic hormone (ACTH) and growth hormone (GH) secretion: a report of two cases and review of the literature.
Rasul FT, Jaunmuktane Z, Khan AA, Phadke R, Powell M.
Acta Neurochir (Wien). 2014 Jan;156(1):141-6. doi: 10.1007/s00701-013-1890-y. Epub 2013 Oct 1.
Coexistence of growth hormone-secreting pituitary adenoma and intracranial meningioma: a case report and review of the literature.
Cannavò S, Curtò L, Fazio R, Paterniti S, Blandino A, Marafioti T, Trimarchi F.
J Endocrinol Invest. 1993 Oct;16(9):703-8. doi: 10.1007/BF03348915.
Malignant growth hormone-secreting pituitary adenoma with hematogenous dural metastasis: case report.
Asai A, Matsutani M, Funada N, Takakura K.
Neurosurgery. 1988 Jun;22(6 Pt 1):1091-4. doi: 10.1227/00006123-198806010-00023.
Growth hormone-secreting adenomas: pathology and cell biology.
Lopes MB.
Neurosurg Focus. 2010 Oct;29(4):E2. doi: 10.3171/2010.7.FOCUS10169.
